TNF and necrotizing vasculitis: Benefits related to TNF-α blockade have already been demonstrated in other pathological conditions, such as acute shocks, rheumatoid arthritis, systemic vasculitis, idiopathic dilated cardiomyopathy and type-1 diabetes mellitus [26].